CROs/Service Providers

Parexel posts revenue increase in second quarter

Tuesday, January 31, 2012 02:23 PM

Boston-based CRO Parexel International posted a 9.5% increase in consolidated service revenue for the second quarter ended Dec. 31, 2011, to $333.2 million, from a year ago.

More... »

Charles River Labs launches online community Eureka

Thursday, January 26, 2012 10:59 AM

Charles River Laboratories has launched Eureka, an online community for scientists “to explore, connect and share big ideas.” The site profiles scientific professionals at Charles River Labs and welcomes industry experts to share their research and opinions on industry topics and questions.

More... »

Clinical Financial Services expands internationally

Wednesday, January 25, 2012 01:50 PM

Clinical Financial Services (CFS), a specialty service provider focused on the business and financial management of clinical trials, has expanded its global presence, opening a new office in Edinburgh, Scotland.

More... »

Parexel forms early-phase alliance with U.K.’s UH Bristol

Tuesday, January 24, 2012 10:46 AM

Parexel International, a Boston-based global biopharmaceutical services provider, has established an alliance with University Hospitals Bristol National Health Service (NHS) Foundation Trust (UH Bristol), one of the largest specialist teaching and research hospital trusts in the United Kingdom.

More... »

ProTrials creates U.K. subsidiary

Tuesday, January 24, 2012 10:40 AM

Sunnyvale, Calif.-based CRO ProTrials Research has created a wholly owned subsidiary to help meet its sponsors’ increasing needs for multi-national, multi-site clinical trials.  Based in the United Kingdom, ProTrials Global will help manage ongoing clinical trials in Italy, Spain and the U.K., and will be responsible for additional growth in the European arena.

More... »

inVentiv Health to acquire SDI businesses from IMS Health

Friday, January 20, 2012 02:53 PM

Burlington, Mass.-based inVentiv Health will acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.  Financial terms were not disclosed.

More... »

CoreLab Partners opens office in Tokyo

Friday, January 20, 2012 02:50 PM

Signaling its plan to expand its business model in the Pacific Rim and build a global presence as a large imaging and cardiac safety core lab, CoreLab Partners is opening of an office in Tokyo under the wholly owned subsidiary CoreLab Partners Japan.

More... »

Quintiles launches innovative Center of Excellence in China

Wednesday, January 18, 2012 04:09 PM

Quintiles is opening a business process outsourcing (BPO) and project management center of excellence in Dalian, China, a major city with a multilingual workforce and location ideally suited to serve the Japanese, Chinese and South Korean biopharmaceutical markets.

More... »

Nikem Research and Dualsystems Biotech form alliance

Monday, January 9, 2012 01:48 PM

Nikem Research and Dualsystems Biotech have joined forces to jointly offer their respective drug/target profiling and drug discovery services to their clients.

More... »

ICON named sole provider of central lab services to Shire

Monday, January 9, 2012 01:45 PM

CRO ICON has signed a strategic partnership with Shire Specialty Pharmaceuticals to serve as the sole global provider of central laboratory services and one of two strategic partners for clinical development services.

More... »